Cognitive Domains and Health-Related Quality of Life in Alzheimer’s Disease
Journals of Gerontology: Psychological Sciences
cite as: J Gerontol B Psychol Sci Soc Sci, 2016, Vol. 71, No. 2, 275–287
doi:10.1093/geronb/gbu090
Advance Access publication August 5, 2014
Original Research Report
Pascalle R. Bosboom1,2 and Osvaldo P. Almeida1,2
Western Australian Centre for Health and Ageing, Centre for Health Research and 2School of Psychiatry and Clinical
Neurosciences, University of Western Australia, Perth, Australia.
1
Correspondence should be addressed to Pascalle R. Bosboom, MSc, Western Australian Centre for Health and Ageing (M573), University of
Western Australia, 35 Stirling Highway, Crawley, Perth WA 6009, Australia. E-mail: .
Received March 12, 2014; Accepted June 14, 2014
Decision Editor: Shevaun Neupert, PhD
Abstract
Objectives: The nature of the association between the cognitive decline and quality of life (QoL) during the course of
Alzheimer’s disease (AD) has not been studied in detail. We designed this study to determine if the association between
cognitive domains in AD and health-related quality of life (HRQoL) changed over 18 months.
Methods: We recruited 80 community-dwelling older adults with mild to moderate AD and 61 healthy elderly controls as
well as their next-of-kin. The primary outcome measure was the QoL-AD. Specific cognitive functions were assessed with
a broad range of neuropsychological measures, which were later grouped into cognitive domains following factor analyses
at the baseline and 18-month assessments. Other explanatory variables included demographics, psychopathology, burden
of care, and use of medication.
Results: Self-reported QoL-AD scores were not associated with any of the identified cognitive domains at either assessment. The cognitive domains of people with AD changed between baseline and the 18-month assessment, as did the association of these factors with carer-rated HRQoL. The HRQoL scores assigned by the next-of-kin declined alongside a general
measure of cognitive function.
Discussion: These results indicate that HRQoL is not consistently associated with specific cognitive domains in AD and
that cognitive-enhancing focused therapies may fail to affect the HRQoL of people with AD.
Key Words: Carer—Cognition—Episodic memory—Health-related quality of life—Quality of life-AD
Cognitive impairment is a core feature of Alzheimer’s disease
(AD) (McKhann et al., 2011) that is expected to undermine
the health-related quality of life (HRQoL) of those affected
(Banerjee et al., 2009; Droes et al., 2006; Jonker, Gerritsen,
Bosboom, & Van Der Steen, 2004; Kaplan, Mausbach,
Marcotte, & Patterson, 2010; Miche et al., 2014; Rabins,
2000). Specific cognitive deficits have been associated with
diminished HRQoL in other chronic diseases, such as epilepsy, schizophrenia, Parkinson’s disease, traumatic brain
injury, and multiple sclerosis (Anderson, Brown, Newitt, &
Hoile, 2011; Barker-Collo, 2006; Hermann, 1993; Leroi,
McDonald, Pantula, & Harbishettar, 2012; Perrine et al.,
1995; Tolman and Kurtz, 2012) but, surprisingly, the relationship between the inevitable cognitive decline of AD and
HRQoL during the course of the illness has not been studied in detail (Hoe, Hancock, Livingston, & Orrell, 2006;
Logsdon, Gibbons, McCurry, & Teri, 2002; Novelli and
Caramelli, 2010; Vogel, Mortensen, Hasselbalch, Andersen,
& Waldemar, 2006). Few studies have investigated the longterm association between overall cognition and HRQoL in
dementia (Bosboom, Alfonso, & Almeida, 2013; Heggie
et al., 2012; Lyketsos et al., 2003; Missotten et al., 2007;
Selwood, Thorgrimsen, & Orrell, 2005; Tatsumi et al.,
2009; Vogel, Bhattacharya, Waldorff, & Waldemar, 2012).
© The Author 2014. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved.
For permissions, please e-mail: .
275
Cognitive Domains and Health-Related Quality of Life in
Alzheimer’s Disease
276
AD throughout the course of their illness). Conversely, if
the underlying cognitive structure is not stable over time,
then different cognitive domains might influence HRQoL
as the disease progresses.
This study aimed to determine whether: (a) the underlying cognitive structure in a sample of older adults with
mild to moderate AD living in the community is stable
over 18 months compared with controls free of dementia,
and (b) the associations between cognitive structure and
carer and self-reported HRQoL ratings remain stable over
18 months.
Method
Study Design
This study was a 18-month longitudinal observational
study of the HRQoL of older adults with AD and healthy
older adults.
Participants and Setting
We recruited 80 community-dwelling volunteers with the
diagnosis of probable AD according to National Institute
of Neurological and Communicative Disorders and
Stroke and the Alzheimer’s Disease and Related Disorders
Association criteria (McKhann et al., 1984). All participants had a total score of 10 or more on the MMSE
(Folstein, Folstein, & McHugh, 1975) at the time of enrolment. Carers had face-to-face contact with the person with
AD at least three times per week over the preceding year.
Participants were recruited from various mental health and
aged care services in the Perth metropolitan area.
Participants for the control group were aged 65 years
or older and were recruited together with their next-of-kin
from other studies running at the School of Psychiatry and
Clinical Neurosciences. We only included cognitively intact
control subjects, that is, volunteers who did not have cognitive complaints, with an MMSE of ≥26, and also did not
meet criteria for AD or MCI. We included 65 control pairs
in this study.
We excluded people with a positive history of alcohol
or substance abuse, and those with a medically unstable
illness that could compromise survival (such as metastatic
cancer). Participants with AD could be taking cholinesterase inhibitors or memantine, but could not be participating
concurrently in an experimental study of medications for
AD. All participants were competent in written and spoken
English.
Assessments were conducted between November 2006
and January 2010. The ethics committees of the University
of Western Australia, Royal Perth Hospital, Mercy
Hospital, and Western Australian Department of HealthNMAHS Mental Health approved the study protocol. All
participants and their carers provided written informed
consent, and the project was conducted in accordance with
the Helsinki Declaration of Human Rights.
However, their findings have relied on brief cognitive
screening tests, such as the Mini-Mental State Examination
(MMSE) and the Cambridge Cognitive Examination of the
Elderly-Revised version (CAMCOG-R), which have limited
sensitivity to measure specific cognitive functions, such as
executive function (Kessels, Mimpen, Melis, & Rikkert,
2009; Martyr & Clare, 2012).
A limited body of research using carer reports to measure
the HRQoL of the AD patient they cared for has provided
data suggesting that (...truncated)